GLAXOSMITHKLINE PLC GSK (NYSE)

$ 46.77
16:06
Change: +1.59 (+3.52%)
Volume: 2,389,000

Avg. Volume: 1585775
P/E Ratio: 12.4
EPS (Annual): 3.58
Profit Margin:
Dividend & Yield(Annual): 4.7%
Shares Outstanding: 2,644,500
Institutional Shareholders: 12.8%
Last: 46.77
Change: +1.59 (+3.52%)
Prev. Close: 45.18
Open: 46.89
Day's Range: 46.18 - 46.98
52wk Range: 39.75 - 53.49
Market Value: 116,939,790
Beta: .21
12-month EPS Change: -5.0%
Total Return Last 12 Months: -11.4%
Total Return Last 3 Years: 2.8%
Total Return Last 5 Years: 30.4%
5-Year Revenue Growth Rate: 4.47%
5-Year Dividend Growth Rate: 12.33%
5-Year EPS Growth Rate: 8.86%


Headlines on GSK
Alert me Subscribe

2 drug firms to appeal $114M price fraud verdict

(MONTGOMERY, Ala.)Two large pharmaceutical companies said Thursday they will appeal a jury verdict ordering them to pay more than $114 million for overcharging the state's Medicaid program for presc...READ MORE
Jul 03, 2008 6:26PM
Keywords: GSK, NVS, AZN, BMY, ABT

Sector Snap: Diabetes drug developers

(NEW YORK)Proposals for tougher heart-risk studies on new Type 2 diabetes drugs weighed heavy on shares of Amylin Pharmaceuticals Inc. and Novo Nordisk AS Thursday, since stricter regulation...READ MORE
Jul 03, 2008 11:34AM
Keywords: AMLN, NVO, ALKS, MRK, BMY, LLY, GSK

FDA lifts clinical hold on Adolor bowel drug

(EXTON, Pa.)Adolor Corp. said Thursday the Food and Drug Administration has lifted its clinical hold on the company's Entereg drug in chronically constipated patients taking opioid pain drugs....READ MORE
Jul 03, 2008 8:33AM
Keywords: ADLR, GSK

FDA panel urges more testing for diabetes drugs

(WASHINGTON)Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.READ MORE
Jul 02, 2008 5:29PM
Keywords: GSK, NVS, AZN, MRK, SGP, AMLN

Brown appoints new business advisers

(LONDON)British Prime Minister Gordon Brown is appointing three top executives as new advisers on his national business council. He says Andrew Witty, chief executive of drug developer Gla...READ MORE
Jul 02, 2008 12:35PM
Keywords: GSK, BT, DEO

Jury: 2 drug firms owe Ala. $114M in price fraud

(MONTGOMERY, Ala.)A state court jury on Tuesday found two major pharmaceutical companies defrauded Alabama in a long-running Medicaid drug pricing scheme and ordered the firms to pay more than $114 ...READ MORE
Jul 01, 2008 7:51PM
Keywords: GSK, NVS, AZN

Ahead of the Bell: FDA reconsiders diabetes drugs

(WASHINGTON)Government regulators are reconsidering how they approve diabetes drugs. They were criticized last year for their handling of heart risks connected with a widely used GlaxoSmithKli...READ MORE
Jul 01, 2008 6:17AM
Keywords: MRK, GSK
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

PFIZER INC -30.20 17.75
MERCK CO INC -24.40 38.45
BRISTOL MYERS S -30.60 20.78
SCHERING PLOUGH -30.90 19.79
WYETH -8.20 46.99